254 filings
Page 8 of 13
8-K
ygmiz1hvim4klrpy4
6 Nov 18
Cara Therapeutics Reports Third Quarter 2018 Financial Results
4:11pm
8-K
z2li61bdsv4gd
23 Oct 18
Departure of Directors or Certain Officers
7:29am
CT ORDER
xxru7epltdlcst2q1omw
11 Sep 18
Confidential treatment order
12:00am
8-K
sik75vj1 0b5evmav3
7 Aug 18
Cara Therapeutics Reports Second Quarter 2018 Financial Results
4:11pm
8-K
oe48pjqdb700gwfnx4
6 Aug 18
Departure of Directors or Certain Officers
4:10pm
8-K
d3kdez wtoyt66n6v
23 Jul 18
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
4:10pm
424B5
038rmj ecx71
20 Jul 18
Prospectus supplement for primary offering
4:12pm
8-K
uavuydjn7wkduk2kp
17 Jul 18
Cara Therapeutics Announces Proposed Offering of Common Stock
5:24pm
424B5
mu6w kfc0o0p
17 Jul 18
Prospectus supplement for primary offering
5:23pm
8-K
kp0plqqazoltdkxytn
27 Jun 18
Cara Therapeutics Reports PositiveTop-Line Data from Adaptive Phase 2/3 Trial of I.V. CR845 in Patients Undergoing Abdominal Surgery
4:06pm
8-K
sfrb6n
8 Jun 18
Submission of Matters to a Vote of Security Holders
4:04pm
8-K
l34bkgm
23 May 18
Cara receives upfront payment of $50 million in cash and an equity investment of $20 million
8:30am
8-K
2x6b58el7pbvq
23 May 18
Entry into a Material Definitive Agreement
6:06am
8-K
8mq54
9 May 18
Cara Therapeutics Reports First Quarter 2018 Financial Results
4:10pm
DEFA14A
d7b04eg7djaj54y
26 Apr 18
Additional proxy soliciting materials
4:16pm
S-8
euvw4 cyltsd2o9s
16 Mar 18
Registration of securities for employees
12:00am